Stay updated on PT2385 Tablets in Advanced RCC Clinical Trial
Sign up to get notified when there's something new on the PT2385 Tablets in Advanced RCC Clinical Trial page.

Latest updates to the PT2385 Tablets in Advanced RCC Clinical Trial page
- Check5 days agoChange DetectedThe study page now displays the ClinicalTrials.gov record for the Phase 1 renal cancer trial, including its study design, treatments, eligibility criteria, outcome measures, and locations, instead of an access-denied error.SummaryDifference78%

- Check12 days agoChange DetectedThe ClinicalTrials.gov page remains an access-denied 403 page; its footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA site-wide NIH transition announcement appears above the page, and the displayed site revision changes from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check40 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link. Previously listed sponsors, institutions, and detailed study content have been removed from the page.SummaryDifference21%

- Check61 days agoChange DetectedFooter revision label updated to v3.7.0, replacing the previous v3.6.6, indicating a site update. This change does not affect the study content or user actions on the page.SummaryDifference0.0%

Stay in the know with updates to PT2385 Tablets in Advanced RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PT2385 Tablets in Advanced RCC Clinical Trial page.